Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPLACING: Robotic Bronchoscopy With Cone CT and Indocyanine Green for Pulmonary Lesions
NCT04987281Phase 2Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2022
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Number of successful procedures out of 50 at 1 year. Planned start Jan 2022; status: withdrawn.
Beyond the preview
Go deeper on NCT04987281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04987281.